相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。AMPK Activation Stimulates Autophagy and Ameliorates Muscular Dystrophy in the mdx Mouse Diaphragm
Marion Pauly et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Pharmacologically Targeting the Primary Defect and Downstream Pathology in Duchenne Muscular Dystrophy
Rebecca J. Fairclough et al.
CURRENT GENE THERAPY (2012)
Restoration of the Dystrophin-associated Glycoprotein Complex After Exon Skipping Therapy in Duchenne Muscular Dystrophy
Sebahattin Cirak et al.
MOLECULAR THERAPY (2012)
Phase 1 Gene Therapy for Duchenne Muscular Dystrophy Using a Translational Optimized AAV Vector
Dawn E. Bowles et al.
MOLECULAR THERAPY (2012)
Nitric oxide donor and non steroidal anti inflammatory drugs as a therapy for muscular dystrophies: Evidence from a safety study with pilot efficacy measures in adult dystrophic patients
Maria Grazia D'Angelo et al.
PHARMACOLOGICAL RESEARCH (2012)
Autophagy in Stem Cell Maintenance and Differentiation
Alexandre Teixeira Vessoni et al.
STEM CELLS AND DEVELOPMENT (2012)
Autophagy induction rescues muscular dystrophy
Paolo Grumati et al.
AUTOPHAGY (2011)
Rapamycin Ameliorates Dystrophic Phenotype in mdx Mouse Skeletal Muscle
Saman Eghtesad et al.
MOLECULAR MEDICINE (2011)
Current Status of Pharmaceutical and Genetic Therapeutic Approaches to Treat DMD
Christophe Pichavant et al.
MOLECULAR THERAPY (2011)
Systemic Administration of PRO051 in Duchenne's Muscular Dystrophy
Nathalie M. Goemans et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
A dual acting compound releasing nitric oxide (NO) and ibuprofen, NCX 320, shows significant therapeutic effects in a mouse model of muscular dystrophy
Clara Sciorati et al.
PHARMACOLOGICAL RESEARCH (2011)
Co-administration of ibuprofen and nitric oxide is an effective experimental therapy for muscular dystrophy, with immediate applicability to humans
Clara Sciorati et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Autophagy in skeletal muscle
Marco Sandri
FEBS LETTERS (2010)
Evaluation of Hydrodynamic Limb Vein Injections in Nonhuman Primates
Julia O. Hegge et al.
HUMAN GENE THERAPY (2010)
Autophagy is defective in collagen VI muscular dystrophies, and its reactivation rescues myofiber degeneration
Paolo Grumati et al.
NATURE MEDICINE (2010)
Smad2 and 3 transcription factors control muscle mass in adulthood
Roberta Sartori et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2009)
Autophagy Is Required to Maintain Muscle Mass
Eva Masiero et al.
CELL METABOLISM (2009)
Control of autophagy initiation by phosphoinositide 3-phosphatase jumpy
Isabelle Vergne et al.
EMBO JOURNAL (2009)
Muscle inactivation of mTOR causes metabolic and dystrophin defects leading to severe myopathy
Valerie Risson et al.
JOURNAL OF CELL BIOLOGY (2009)
Glutamatergic Reinnervation and Assembly of Glutamatergic Synapses in Adult Rat Skeletal Muscle Occurs at Cholinergic Endplates
Maura Francolini et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2009)
Downstream of Akt: FoxO3 and m TOR in the regulation ofautophagy in skeltal muscle
Cristina Mammucari et al.
AUTOPHAGY (2008)
Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes
Daniel J. Klionsky et al.
AUTOPHAGY (2008)
Suppression of autophagy in skeletal muscle uncovers the accumulation of ubiquitinated proteins and their potential role in muscle damage in Pompe disease
Nina Raben et al.
HUMAN MOLECULAR GENETICS (2008)
Genetic and pharmacologic inhibition of mitochondrial-dependent necrosis attenuates muscular dystrophy
Douglas P. Millay et al.
NATURE MEDICINE (2008)
HDAC2 blockade by nitric oxide and histone deacetylase inhibitors reveals a common target in Duchenne muscular dystrophy treatment
Claudia Colussi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice
Masaaki Komatsu et al.
CELL (2007)
FoxO3 controls autophagy in skeletal muscle in vivo
Cristina Mammucari et al.
CELL METABOLISM (2007)
FoxO3 coordinately activates protein degradation by the Autophagic/Lysosomal and proteasomal pathways in atrophying muscle cells
Jinghui Zhao et al.
CELL METABOLISM (2007)
Necdin mediates skeletal muscle regeneration by promoting myoblast survival and differentiation
Daniela Deponti et al.
JOURNAL OF CELL BIOLOGY (2007)
Nitric oxide release combined with nonsteroidal anti inflammatory activity prevents muscular dystrophy pathology and enhances stem cell therapy
Silvia Brunelli et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Self-eating and self-killing: crosstalk between autophagy and apoptosis
M. Chiara Maiuri et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Ex vivo treatment with nitric oxide increases mesoangioblast therapeutic efficacy in muscular dystrophy
Clara Sciorati et al.
JOURNAL OF CELL SCIENCE (2006)
Functional and morphological recovery of dystrophic muscles in mice treated with deacetylase inhibitors
G. C. Minetti et al.
NATURE MEDICINE (2006)
Hypertrophic response of Duchenne and limb-girdle muscular dystrophies is associated with activation of Akt pathway
Angela K. Peter et al.
EXPERIMENTAL CELL RESEARCH (2006)
Regulation of phosphatidylinositol 3-kinase (Pl3K)/Akt and nuclear factor-kappa B signaling pathways in dystrophin-deficient skeletal muscle in response to mechanical stretch
Charu Dogra et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2006)
In vivo analysis of autophagy in response to nutrient starvation using transgenic mice expressing a fluorescent autophagosome marker
N Mizushima et al.
MOLECULAR BIOLOGY OF THE CELL (2004)
Autophagy in health and disease: A double-edged sword
T Shintani et al.
SCIENCE (2004)
Steroids in Duchenne muscular dystrophy: from clinical trials to genomic research
F Muntoni et al.
NEUROMUSCULAR DISORDERS (2002)
A protein kinase B-dependent and rapamycin-sensitive pathway controls skeletal muscle growth but not fiber type specification
G Pallafacchina et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Drastic reduction of calsequestrin-like proteins and impaired calcium binding in dystrophic mdx muscle
K Culligan et al.
JOURNAL OF APPLIED PHYSIOLOGY (2002)
Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo
SC Bodine et al.
NATURE CELL BIOLOGY (2001)
分享论文
